• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端黑素瘤的临床特征、分子病理学和免疫微环境特征。

Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.

机构信息

Cancer Center, The First Hospital of Jilin University, 1 Xinmin St, Changchun, 130021, China.

出版信息

J Transl Med. 2022 Aug 16;20(1):367. doi: 10.1186/s12967-022-03532-2.

DOI:10.1186/s12967-022-03532-2
PMID:35974375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9382740/
Abstract

Acral melanoma (AM) has unique biology as an aggressive subtype of melanoma. It is a common subtype of melanoma in races with darker skin tones usually diagnosed at a later stage, thereby presenting a worse prognosis compared to cutaneous melanoma. The pathogenesis of acral melanoma differs from cutaneous melanoma, and trauma promotes its development. Compared to cutaneous melanomas, acral melanomas have a significantly lighter mutational burden with more copy number variants. Most acral melanomas are classified as triple wild-type. In contrast to cutaneous melanomas, acral melanomas have a suppressive immune microenvironment. Herein, we reviewed the clinical features, genetic variants, and immune microenvironmental characteristics of limbic melanomas to summarise their unique features.

摘要

肢端黑色素瘤(AM)作为一种侵袭性黑色素瘤亚型,具有独特的生物学特性。它是深色皮肤人群中常见的黑色素瘤亚型,通常在晚期诊断,因此与皮肤黑色素瘤相比预后更差。肢端黑色素瘤的发病机制不同于皮肤黑色素瘤,创伤可促进其发生发展。与皮肤黑色素瘤相比,肢端黑色素瘤的突变负担明显较轻,并有更多的拷贝数变异。大多数肢端黑色素瘤被归类为三野生型。与皮肤黑色素瘤不同,肢端黑色素瘤具有抑制性的免疫微环境。本文综述了肢端黑色素瘤的临床特征、遗传变异和免疫微环境特征,以总结其独特的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7b6/9382740/2549af2eefdc/12967_2022_3532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7b6/9382740/2549af2eefdc/12967_2022_3532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7b6/9382740/2549af2eefdc/12967_2022_3532_Fig1_HTML.jpg

相似文献

1
Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.肢端黑素瘤的临床特征、分子病理学和免疫微环境特征。
J Transl Med. 2022 Aug 16;20(1):367. doi: 10.1186/s12967-022-03532-2.
2
Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.部分肢端和皮肤黑色素瘤中意外的紫外线辐射(UVR)和非紫外线辐射突变负担
Lab Invest. 2017 Feb;97(2):130-145. doi: 10.1038/labinvest.2016.143. Epub 2017 Jan 9.
3
Targeted Genomic Profiling of Acral Melanoma.肢端黑色素瘤的靶向基因组分析。
J Natl Cancer Inst. 2019 Oct 1;111(10):1068-1077. doi: 10.1093/jnci/djz005.
4
Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.基于部位和相对日照的肢端黑素瘤的不同模式。
J Invest Dermatol. 2018 Feb;138(2):384-393. doi: 10.1016/j.jid.2017.08.022. Epub 2017 Sep 1.
5
Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.韩国肢端黑素瘤和肢端黑素细胞痣中的遗传改变:常见突变基因显示出不同的细胞学形态特征。
J Invest Dermatol. 2018 Apr;138(4):933-945. doi: 10.1016/j.jid.2017.11.017. Epub 2017 Nov 27.
6
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.通过全基因组测序和比较分析揭示的肢端黑色素瘤的突变负担
Pigment Cell Melanoma Res. 2014 Sep;27(5):835-8. doi: 10.1111/pcmr.12279. Epub 2014 Jun 30.
7
Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments.绘制肢端黑色素瘤的单细胞图谱,并分析肿瘤微环境的分子调控网络。
Elife. 2022 Jul 27;11:e78616. doi: 10.7554/eLife.78616.
8
Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.根据亚型分析黑素瘤中 KIT 基因突变的分布和临床作用:西班牙 492 例患者研究。
Eur J Dermatol. 2021 Dec 1;31(6):830-838. doi: 10.1684/ejd.2021.3971.
9
Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.肢端和黏膜黑色素瘤的综合基因组分析鉴定出新的驱动基因。
Genome Med. 2022 Jun 16;14(1):65. doi: 10.1186/s13073-022-01068-0.
10
Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?肢端黑色素瘤的存活率真的比其他皮肤黑色素瘤差吗?
J Dermatol. 2020 Mar;47(3):251-256. doi: 10.1111/1346-8138.15201. Epub 2019 Dec 30.

引用本文的文献

1
Multivariate analysis and prediction model construction for distant metastasis of Acral Melanoma.肢端黑色素瘤远处转移的多因素分析及预测模型构建
Am J Cancer Res. 2025 Aug 25;15(8):3678-3692. doi: 10.62347/OLPB3585. eCollection 2025.
2
Association between Ki-67 and clinical outcomes in 324 Chinese patients with resectable acral melanoma.324例中国可切除性肢端黑色素瘤患者中Ki-67与临床结局的相关性
Sci Rep. 2025 Aug 17;15(1):30130. doi: 10.1038/s41598-025-15751-w.
3
A distinct subgroup with Schwann-like differentiation presents immune resistance and poor prognosis in plantar melanoma.

本文引用的文献

1
Differences by Anatomical Site of Non-Acral Lentiginous Melanomas of the Lower Limb.下肢非肢端雀斑样黑素瘤的解剖部位差异。
Dermatology. 2022;238(5):977-985. doi: 10.1159/000522492. Epub 2022 Mar 29.
2
Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.整合基因组分析揭示亚洲人群肢端黑色素瘤的治疗靶点。
Clin Cancer Res. 2022 Jun 13;28(12):2690-2703. doi: 10.1158/1078-0432.CCR-21-3344.
3
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy.
具有施万细胞样分化的独特亚组在足底黑色素瘤中表现出免疫抵抗和预后不良。
Theranostics. 2025 Mar 3;15(9):3900-3923. doi: 10.7150/thno.99526. eCollection 2025.
4
Acral Melanoma in Skin of Color: Current Insights and Future Directions: A Narrative Review.有色人种皮肤肢端黑色素瘤:当前见解与未来方向:一篇叙述性综述
Cancers (Basel). 2025 Jan 30;17(3):468. doi: 10.3390/cancers17030468.
5
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial.奥昔布宁瘤内注射联合特瑞普利单抗治疗可切除肢端黑色素瘤的 Ib 期临床试验。
Signal Transduct Target Ther. 2024 Nov 22;9(1):318. doi: 10.1038/s41392-024-02029-2.
6
Clinicopathological features, response patterns, outcomes and BRAF status in patients with advanced acral melanoma: a preliminary Peruvian study.晚期肢端黑色素瘤患者的临床病理特征、反应模式、预后及BRAF状态:一项秘鲁的初步研究。
Ecancermedicalscience. 2024 Aug 27;18:1749. doi: 10.3332/ecancer.2024.1749. eCollection 2024.
7
Identification of two molecularly and prognostically distinct subtypes in acral melanoma using network prediction method.使用网络预测方法鉴定肢端黑色素瘤中两种分子和预后不同的亚型。
J Eur Acad Dermatol Venereol. 2025 Jul;39(7):1254-1266. doi: 10.1111/jdv.20335. Epub 2024 Sep 16.
8
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.恶性黑色素瘤:概述、新观点及维生素D信号传导
Cancers (Basel). 2024 Jun 18;16(12):2262. doi: 10.3390/cancers16122262.
9
Editorial: Multidisciplinary treatment and precision medicine for acral and mucosal melanoma.社论:肢端和黏膜黑色素瘤的多学科治疗与精准医学
Front Oncol. 2024 May 30;14:1429030. doi: 10.3389/fonc.2024.1429030. eCollection 2024.
10
Clinical characteristics, survival analysis and influencing factors of distant metastasis in patients with acromelanomas: A retrospective study.肢端黑素瘤患者远处转移的临床特征、生存分析及影响因素:一项回顾性研究。
Medicine (Baltimore). 2024 Jun 7;103(23):e38230. doi: 10.1097/MD.0000000000038230.
肢端黑色素瘤细胞图谱的单细胞特征鉴定出免疫治疗的新靶点。
Clin Cancer Res. 2022 May 13;28(10):2131-2146. doi: 10.1158/1078-0432.CCR-21-3145.
4
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.肢端黑色素瘤的综合分子与临床特征分析提示 22q11.21 局灶扩增与转移相关。
Nat Commun. 2022 Feb 23;13(1):898. doi: 10.1038/s41467-022-28566-4.
5
Clinicopathological characteristics and prognosis in significantly thick acral lentiginous melanoma in Taiwan.台湾显著增厚肢端雀斑样黑素瘤的临床病理特征和预后。
J Formos Med Assoc. 2022 Nov;121(11):2338-2344. doi: 10.1016/j.jfma.2021.12.001. Epub 2021 Dec 25.
6
CD103+ T Lymphocyte Count Linked to the Thickness of Invasion on Acral Melanoma without E-Cadherin Involvement.CD103+ T淋巴细胞计数与肢端黑色素瘤侵袭深度相关,与E-钙黏蛋白无关。
Clin Cosmet Investig Dermatol. 2021 Nov 24;14:1783-1790. doi: 10.2147/CCID.S334984. eCollection 2021.
7
MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.MCAM/MUC18/CD146 作为液体活检中黑色素瘤进展的多方面预警标志物。
Int J Mol Sci. 2021 Nov 17;22(22):12416. doi: 10.3390/ijms222212416.
8
Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.肢端雀斑样黑素瘤:美国多中心亚分期生存分析。
Cancer Control. 2021 Jan-Dec;28:10732748211053567. doi: 10.1177/10732748211053567.
9
The tumor genetics of acral melanoma: What should a dermatologist know?肢端黑色素瘤的肿瘤遗传学:皮肤科医生应该了解什么?
JAAD Int. 2020 Dec;1(2):135-147. doi: 10.1016/j.jdin.2020.07.004. Epub 2020 Aug 13.
10
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.肢端和黏膜黑色素瘤的免疫治疗:现状和未来方向。
Front Immunol. 2021 Jun 4;12:680407. doi: 10.3389/fimmu.2021.680407. eCollection 2021.